SENSIUM, part of The Surgical Company, is a global pioneer in wireless monitoring of vital signs. The company’s focus is on ultra-low power, lightweight, monitoring solutions which improve patient care and safety, shorten hospital stays and reduce healthcare costs.
Set to transform in-hospital vital signs monitoring, the Sensium ‘early warning’ system uses world-leading wireless innovation, with proven performance and reliability, to deliver essential, clinical support alongside ultimate patient comfort, confidence and mobility. Sensium was developed over a decade by world-renowned digital healthcare experts, including Professor Toumazou, Regius Professor of Engineering and founding director of the Institute of Biomedical Engineering at Imperial College. SENSIUM joined The Surgical Company Group in 2016, supporting a joint mission to provide the best tools and services to medical staff for the best possible treatment of their patients. Visit our careers page for current SENSIUM vacancies.
2000 - Company founded as “Toumaz Technology”, providing products and services based on very low power wireless technology originally developed at Imperial College London.
2007 - The Sensium silicon integrated circuit, the world’s first ‘System-on-Chip (SoC)’ for low power, wearable, wireless vital signs monitoring, is developed
2010 - The SensiumVitals end-to-end system for early detection of patient deterioration undergoes first in-patient trials at St Mary’s Hospital London
2011 - SensiumVitals is FDA 510(k) cleared
2013 - CE Mark awarded for SensiumVitals
2016 - Sensium Healthcare spins out of Toumaz to become part of The Surgical Company Group
2018 - First Sensium iOS app deployed. Pilot studies completed at St James’s University Hospital, Leeds, demonstrating clinical benefits for patients.
2019 -First deployment of electronic observations/ early warning score capability and integration with a Hospital Electronic Medical record (EMR)
2020 - First Sensium Android app deployed. Sensium obtains ISO27001 certification.